Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice
- PMID: 10534116
Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice
Abstract
Chronic intermittent injection of carbon tetrachloride (CCl4) for more than 10 weeks induced liver fibrosis in mice, as evidenced by positive Azan staining and increased intrahepatic collagen content. Preceding the onset of liver fibrosis, interleukin-6 (IL-6) gene expression was enhanced in liver and immunoreactive IL-6 was detected in infiltrating inflammatory cells. To delineate the role of IL-6 in this process, we treated IL-6-deficient mice with CCl4 in a similar manner for 12 weeks, after which fibrotic changes were less evident and serum albumin levels were lower in IL-6-deficient than wild-type mice. Moreover, CCl4-induced expression of transforming growth factor beta1 and hepatocyte growth factor genes in liver was significantly reduced in IL-6-deficient mice. Thus, IL-6 may be vitally involved in fibrotic changes and maintenance of serum albumin levels, partly by modulating intrahepatic expression of these cytokines.
Similar articles
-
Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.Acta Pharmacol Sin. 2006 Apr;27(4):469-76. doi: 10.1111/j.1745-7254.2006.00304.x. Acta Pharmacol Sin. 2006. PMID: 16539848
-
All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production.Liver Int. 2008 Nov;28(9):1217-25. doi: 10.1111/j.1478-3231.2008.01745.x. Epub 2008 Apr 7. Liver Int. 2008. PMID: 18397230
-
Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.Liver Int. 2008 Jan;28(1):126-31. doi: 10.1111/j.1478-3231.2007.01616.x. Epub 2007 Nov 1. Liver Int. 2008. PMID: 17976157
-
Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.Wound Repair Regen. 2004 Jan-Feb;12(1):60-6. doi: 10.1111/j.1067-1927.2004.012112.x. Wound Repair Regen. 2004. PMID: 14974966
-
Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen.Clin Exp Allergy. 2004 Aug;34(8):1321-8. doi: 10.1111/j.1365-2222.2004.02013.x. Clin Exp Allergy. 2004. PMID: 15298576
Cited by
-
Therapeutic and diagnostic _targeting of fibrosis in metabolic, proliferative and viral disorders.Adv Drug Deliv Rev. 2021 Aug;175:113831. doi: 10.1016/j.addr.2021.113831. Epub 2021 Jun 15. Adv Drug Deliv Rev. 2021. PMID: 34139255 Free PMC article. Review.
-
Deriving a Boolean dynamics to reveal macrophage activation with in vitro temporal cytokine expression profiles.BMC Bioinformatics. 2019 Dec 18;20(1):725. doi: 10.1186/s12859-019-3304-5. BMC Bioinformatics. 2019. PMID: 31852428 Free PMC article.
-
Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation.Sci Rep. 2019 Nov 26;9(1):17558. doi: 10.1038/s41598-019-54175-1. Sci Rep. 2019. PMID: 31772282 Free PMC article.
-
Role of Interleukin-6 Family Cytokines in Organ Fibrosis.Kidney Dis (Basel). 2023 Mar 22;9(4):239-253. doi: 10.1159/000530288. eCollection 2023 Aug. Kidney Dis (Basel). 2023. PMID: 37900004 Free PMC article. Review.
-
Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis.Front Immunol. 2023 Oct 4;14:1259246. doi: 10.3389/fimmu.2023.1259246. eCollection 2023. Front Immunol. 2023. PMID: 37860002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases